Rock Springs Capital Management as of Dec. 31, 2020
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 154 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Neurocrine Biosciences (NBIX) | 3.2 | $151M | 1.6M | 95.85 | |
Irhythm Technologies (IRTC) | 3.1 | $148M | 625k | 237.21 | |
UnitedHealth (UNH) | 3.0 | $142M | 405k | 350.68 | |
Humana (HUM) | 2.5 | $117M | 285k | 410.27 | |
Zai Lab Adr (ZLAB) | 2.5 | $116M | 855k | 135.34 | |
Agios Pharmaceuticals (AGIO) | 2.3 | $109M | 2.5M | 43.33 | |
Intuitive Surgical Com New (ISRG) | 2.1 | $98M | 120k | 818.10 | |
Blueprint Medicines (BPMC) | 2.0 | $94M | 842k | 112.15 | |
Align Technology (ALGN) | 1.9 | $87M | 164k | 534.38 | |
ACADIA Pharmaceuticals (ACAD) | 1.8 | $86M | 1.6M | 53.46 | |
Argenx Se Sponsored Adr (ARGX) | 1.8 | $85M | 288k | 294.09 | |
Mirati Therapeutics | 1.7 | $82M | 373k | 219.64 | |
Insulet Corporation (PODD) | 1.7 | $81M | 318k | 255.63 | |
Ultragenyx Pharmaceutical (RARE) | 1.7 | $78M | 567k | 138.43 | |
Invitae (NVTAQ) | 1.6 | $77M | 1.9M | 41.81 | |
Hca Holdings (HCA) | 1.6 | $74M | 450k | 164.46 | |
Freshpet (FRPT) | 1.5 | $72M | 507k | 141.99 | |
Atea Pharmaceuticals (AVIR) | 1.5 | $71M | 1.7M | 41.78 | |
Nevro (NVRO) | 1.4 | $68M | 395k | 173.10 | |
EXACT Sciences Corporation (EXAS) | 1.4 | $64M | 485k | 132.49 | |
Arvinas Ord (ARVN) | 1.3 | $63M | 746k | 84.93 | |
Novavax Com New (NVAX) | 1.3 | $63M | 563k | 111.51 | |
IDEXX Laboratories (IDXX) | 1.3 | $63M | 125k | 499.87 | |
Pacira Pharmaceuticals (PCRX) | 1.3 | $61M | 1.0M | 59.84 | |
Beigene Sponsored Adr (BGNE) | 1.2 | $58M | 225k | 258.39 | |
Biogen Idec (BIIB) | 1.2 | $56M | 230k | 244.86 | |
Sarepta Therapeutics (SRPT) | 1.2 | $56M | 329k | 170.49 | |
Mersana Therapeutics (MRSN) | 1.2 | $55M | 2.1M | 26.61 | |
Teleflex Incorporated (TFX) | 1.1 | $54M | 130k | 411.57 | |
Edwards Lifesciences (EW) | 1.1 | $53M | 582k | 91.23 | |
Alexion Pharmaceuticals | 1.0 | $48M | 307k | 156.24 | |
Allakos (ALLK) | 1.0 | $48M | 342k | 140.00 | |
Phreesia (PHR) | 1.0 | $46M | 850k | 54.26 | |
Horizon Therapeutics Pub L SHS | 1.0 | $46M | 625k | 73.15 | |
Kymera Therapeutics (KYMR) | 0.9 | $44M | 714k | 62.00 | |
Centene Corporation (CNC) | 0.9 | $44M | 730k | 60.03 | |
Seagen | 0.9 | $44M | 250k | 175.14 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $44M | 335k | 129.97 | |
Encompass Health Corp (EHC) | 0.9 | $41M | 500k | 82.69 | |
Immunovant (IMVT) | 0.9 | $41M | 891k | 46.19 | |
Eargo | 0.9 | $40M | 900k | 44.82 | |
Inspire Med Sys (INSP) | 0.9 | $40M | 213k | 188.09 | |
Spruce Biosciences (SPRB) | 0.8 | $40M | 1.6M | 24.31 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $39M | 234k | 166.78 | |
Adaptive Biotechnologies Cor (ADPT) | 0.8 | $38M | 635k | 59.13 | |
Covetrus | 0.8 | $37M | 1.3M | 28.74 | |
Acadia Healthcare (ACHC) | 0.7 | $35M | 700k | 50.26 | |
Pulmonx Corp (LUNG) | 0.7 | $35M | 500k | 69.02 | |
Health Catalyst (HCAT) | 0.7 | $34M | 785k | 43.53 | |
Ardelyx (ARDX) | 0.7 | $33M | 5.1M | 6.47 | |
Nkarta (NKTX) | 0.7 | $33M | 541k | 61.47 | |
Novocure Ord Shs (NVCR) | 0.6 | $30M | 175k | 173.04 | |
Athira Pharma (ATHA) | 0.6 | $30M | 861k | 34.25 | |
Boston Scientific Corporation (BSX) | 0.6 | $29M | 800k | 35.95 | |
Bright Horizons Fam Sol In D (BFAM) | 0.6 | $29M | 166k | 172.99 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $29M | 257k | 111.17 | |
Travere Therapeutics (TVTX) | 0.6 | $28M | 1.0M | 27.25 | |
Penumbra (PEN) | 0.6 | $28M | 159k | 175.00 | |
Epizyme | 0.6 | $28M | 2.6M | 10.86 | |
Mirum Pharmaceuticals (MIRM) | 0.6 | $26M | 1.5M | 17.46 | |
Incyte Corporation (INCY) | 0.6 | $26M | 300k | 86.98 | |
Prelude Therapeutics (PRLD) | 0.5 | $26M | 360k | 71.55 | |
Guardant Health (GH) | 0.5 | $26M | 200k | 128.88 | |
Shattuck Labs (STTK) | 0.5 | $26M | 489k | 52.41 | |
Tg Therapeutics (TGTX) | 0.5 | $25M | 489k | 52.02 | |
Karuna Therapeutics Ord | 0.5 | $25M | 244k | 101.59 | |
Baxter International (BAX) | 0.5 | $24M | 301k | 80.24 | |
Royalty Pharma Shs Class A (RPRX) | 0.5 | $24M | 480k | 50.05 | |
Spero Therapeutics (SPRO) | 0.5 | $24M | 1.2M | 19.39 | |
Amicus Therapeutics (FOLD) | 0.5 | $24M | 1.0M | 23.09 | |
Oak Street Health | 0.5 | $23M | 375k | 61.16 | |
Shockwave Med | 0.5 | $23M | 220k | 103.72 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $22M | 254k | 87.69 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.5 | $22M | 1.1M | 20.03 | |
Rocket Pharmaceuticals (RCKT) | 0.5 | $22M | 400k | 54.84 | |
Accolade (ACCD) | 0.5 | $22M | 500k | 43.50 | |
Amarin Corp Spons Adr New (AMRN) | 0.4 | $21M | 4.2M | 4.89 | |
Coherus Biosciences (CHRS) | 0.4 | $20M | 1.2M | 17.38 | |
Abcam Ads | 0.4 | $20M | 925k | 21.55 | |
Ppd | 0.4 | $18M | 525k | 34.22 | |
Gamida Cell SHS | 0.4 | $18M | 2.1M | 8.39 | |
Aclaris Therapeutics (ACRS) | 0.4 | $17M | 2.7M | 6.47 | |
Cytokinetics Note 4.000%11/1 (Principal) | 0.4 | $17M | 8.0M | 2.16 | |
Inozyme Pharma (INZY) | 0.4 | $17M | 831k | 20.64 | |
Relay Therapeutics (RLAY) | 0.4 | $17M | 412k | 41.56 | |
Rigel Pharmaceuticals Com New | 0.4 | $17M | 4.7M | 3.50 | |
Kura Oncology (KURA) | 0.4 | $17M | 508k | 32.66 | |
Cerevel Therapeutics Hldng I (CERE) | 0.4 | $17M | 999k | 16.58 | |
Galapagos Nv Spon Adr (GLPG) | 0.3 | $16M | 165k | 98.98 | |
Intersect Ent | 0.3 | $16M | 700k | 22.90 | |
Protara Therapeutics Com Stk (TARA) | 0.3 | $16M | 643k | 24.21 | |
Rhythm Pharmaceuticals (RYTM) | 0.3 | $15M | 490k | 29.73 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.3 | $14M | 88k | 165.05 | |
Myovant Sciences | 0.3 | $14M | 515k | 27.62 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.3 | $14M | 16M | 0.91 | |
Applied Therapeutics (APLT) | 0.3 | $14M | 636k | 22.01 | |
Gw Pharmaceuticals Ads | 0.3 | $14M | 119k | 115.41 | |
Compugen Ord (CGEN) | 0.3 | $14M | 1.1M | 12.11 | |
Prothena Corp SHS (PRTA) | 0.3 | $14M | 1.1M | 12.01 | |
Akero Therapeutics (AKRO) | 0.3 | $13M | 515k | 25.80 | |
Kinnate Biopharma | 0.3 | $13M | 325k | 39.78 | |
Aeglea Biotherapeutics | 0.3 | $12M | 1.6M | 7.87 | |
Five Prime Therapeutics | 0.3 | $12M | 722k | 17.01 | |
Theravance Biopharma (TBPH) | 0.3 | $12M | 678k | 17.77 | |
Translate Bio | 0.3 | $12M | 644k | 18.43 | |
Fibrogen (FGEN) | 0.2 | $12M | 309k | 37.09 | |
Fusion Pharmaceuticals | 0.2 | $11M | 948k | 11.75 | |
Ngm Biopharmaceuticals | 0.2 | $11M | 361k | 30.29 | |
10x Genomics Cl A Com (TXG) | 0.2 | $11M | 76k | 141.61 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $11M | 774k | 13.83 | |
Chinook Therapeutics | 0.2 | $11M | 669k | 15.86 | |
Paratek Pharmaceuticals | 0.2 | $11M | 1.7M | 6.26 | |
Chiasma | 0.2 | $9.3M | 2.1M | 4.35 | |
Trillium Therapeutics Com New | 0.2 | $9.1M | 619k | 14.71 | |
Sierra Oncology Com New | 0.2 | $9.1M | 567k | 16.03 | |
CONMED Corporation (CNMD) | 0.2 | $8.7M | 78k | 112.00 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.2 | $8.7M | 309k | 28.16 | |
Nurix Therapeutics (NRIX) | 0.2 | $8.5M | 257k | 32.88 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $8.3M | 1.5M | 5.39 | |
West Pharmaceutical Services (WST) | 0.2 | $8.1M | 29k | 283.30 | |
Imara | 0.2 | $7.9M | 361k | 22.05 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $7.9M | 515k | 15.38 | |
Uniqure Nv SHS (QURE) | 0.2 | $7.5M | 209k | 36.13 | |
Dynavax Technologies Corp Com New (DVAX) | 0.2 | $7.3M | 1.6M | 4.45 | |
Atreca Cl A Com (BCEL) | 0.2 | $7.3M | 451k | 16.15 | |
Odonate Therapeutics Ord | 0.2 | $7.3M | 378k | 19.20 | |
Macrogenics (MGNX) | 0.2 | $7.1M | 310k | 22.86 | |
Onespaworld Holdings Ltd onespaworld hold (OSW) | 0.1 | $7.0M | 690k | 10.14 | |
Insmed Note 1.750% 1/1 (Principal) | 0.1 | $6.8M | 6.0M | 1.13 | |
Constellation Pharmceticls I | 0.1 | $6.7M | 233k | 28.80 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $6.7M | 309k | 21.50 | |
Galera Therapeutics (GRTX) | 0.1 | $5.8M | 568k | 10.23 | |
Iteos Therapeutics (ITOS) | 0.1 | $5.4M | 160k | 33.82 | |
Healthequity (HQY) | 0.1 | $5.2M | 75k | 69.71 | |
Panacea Acquisition Corp Unit 99/99/9999 | 0.1 | $5.1M | 402k | 12.76 | |
Certara Ord (CERT) | 0.1 | $5.1M | 150k | 33.72 | |
Acelrx Pharmaceuticals | 0.1 | $4.7M | 3.8M | 1.24 | |
Phasebio Pharmaceuticals | 0.1 | $4.4M | 1.3M | 3.36 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $3.4M | 309k | 11.14 | |
Retrophin Note 2.500% 9/1 (Principal) | 0.1 | $3.3M | 3.3M | 1.02 | |
Poseida Therapeutics I (PSTX) | 0.1 | $3.2M | 290k | 10.97 | |
Global Cord Blood Corporatio SHS (CORBF) | 0.1 | $2.9M | 775k | 3.71 | |
Lifesci Acquisition Ii Corp | 0.0 | $2.2M | 206k | 10.67 | |
Eucrates Biomedical Acqu Cor Unit 10/23/2027 | 0.0 | $2.2M | 206k | 10.66 | |
Jiya Acquisition Corp Com Cl A | 0.0 | $2.1M | 206k | 10.30 | |
Turmeric Acquisition Corp Unit 10/08/2025 | 0.0 | $2.1M | 206k | 10.27 | |
Population Health Invs Co In Unit 99/99/9999 | 0.0 | $2.1M | 201k | 10.45 | |
Helix Acquisition Corp Com Cl A | 0.0 | $1.8M | 155k | 11.37 | |
Theravance Biopharma Note 3.250%11/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.95 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.4M | 1.0M | 1.39 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.3M | 1.5M | 0.90 | |
Pacira Biosciences Note 2.375% 4/0 (Principal) | 0.0 | $1.1M | 1.0M | 1.15 | |
Annexon (ANNX) | 0.0 | $1.1M | 45k | 25.04 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $912k | 500k | 1.82 |